Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3. The change is cosmetic and does not alter content or functionality of the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:00:12.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-13T12:22:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added. Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-05T23:44:53.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed from the study documents.
    Difference
    0.0%
    Check dated 2026-01-15T04:29:00.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all trial sites by state. Removed the separate state-specific location headings (Arizona Locations, California Locations, etc.).
    Difference
    1%
    Check dated 2025-12-24T14:46:24.000Z thumbnail image
  8. Check
    113 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 on the page, indicating a minor site update. No changes to study content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:45:00.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.